JPRN-UMIN000016995招募中未知
Evaluation of antiviral effects of the combination therapy of daclatasvir and asunaprevir - GLSG DCV/ASV
Gunma University Graduate School of Medicine0 个研究点目标入组 100 人开始时间: 2019年10月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients having the history of allergy to Daclatasvir and Asunaprevir 2. Women with pregnancy, having a possibility of pregnancy and during lactation 3. Patients taking a medicine described as a contraindication in a package insert. However, these patients can participate the study one month after discontinuation of the drug. 4. Patients whom the primary doctor thinks inapproprioate for participating the study.
研究者
相似试验
招募中
3 期
Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised control trialCTRI/2020/06/025575AIIMS Rishikesh
进行中（未招募）
1 期
A Phase III Study of the Safety and Efficacy or Entecavir in Pediatric Patients with Chronic HBV-InfectioCHRONIC HEPATITIS B VIRUS,PEDIATRICMedDRA version: 14.1Level: PTClassification code 10008910Term: Chronic hepatitis BSystem Organ Class: 10021881 - Infections and infestationsEUCTR2009-016357-17-BEBristol-Myers Squibb International Corporation180
已完成
3 期
Comparative study in childrens with chronic Hepatitis B virus infection who are HBeAg positive.CTRI/2011/09/002001The pharmaceutical company sponsoring this study is BristolMyers Squibb180
进行中（未招募）
1 期
A Comparative Study of the Antiviral Efficacy and Safety of Entecavir (ETV) versus Placebo in Pediatric Subjects with Chronic Hepatitis B Virus (HBV) Infection who are HBeAg-PositiveCHRONIC HEPATITIS B VIRUS,PEDIATRICMedDRA version: 12.1Level: LLTClassification code 10008910Term: Chronic hepatitis BEUCTR2009-016357-17-GRBristol-Myers Squibb International Corporation257
进行中（未招募）
不适用
A Comparative Study of the Antiviral Efficacy and Safety of Entecavir Plus Tenofovir versus Adefovir Added to Continuing Lamivudine in Adults with Lamivudine Resistant Chronic Hepatitis B Virus Infection. - NDHepatitis B VirusMedDRA version: 9.1Level: LLTClassification code 10008910Term: Chronic hepatitis BEUCTR2007-001269-14-ITBRISTOL-M.SQUIBB84